Screening For Islet Cell Antibodies In Non-Diabetic Siblings of Children With Type I Diabetes Mellitus | ||||
| Minia Journal of Medical Research | ||||
| Volume 31, Issue 4, October 2020, Page 162-165 PDF (155.49 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2022.217626 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Basma A. Ali; Suzan M. Omar; , Noha A. Hussain; Tarek M. Osman | ||||
| Department of Pediatrics, El-Minia Faculty of Medicine | ||||
| Abstract | ||||
| Type I Diabetes Mellitus (TIDM) is the most common chronic metabolic autoimmune disease. Aim of the work: To estimate serum levels of Islet cell antibodies (ICA) in first-degree relatives of type I diabetic children. Subjects and Methods: Study Design: This study was a prospective case-control hospital-based study carried upon 120 children randomly selected during the period from January 2016 till August 2016 after approval of the ethical committee of the Faculty of Medicine, Minia University. Results: This table shows insignificant differences between group I and group II regarding age, gender, residence, weight, height, and BMI centiles where (P > 0.05). Finally, ICA positivity had a significant moderate negative correlation with fasting C-peptide | ||||
| Keywords | ||||
| Type I Diabetes Mellitus; chronic metabolic; Islet cell antibodies | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 120 PDF Download: 199 |
||||
